Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus

Despite recent advances in therapy for chronic hepatitis C (CHC), the disease caused by genotype 3 virus (GEN3) is still considered a treatment challenge in certain patient subgroups. The aim of this retrospective study was to evaluate the effectiveness and safety of the peginterferon (Peg-IFN) and...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Rev Inst Med Trop Sao Paulo
Κύριοι συγγραφείς: Grando, Aline Vitali, Ferreira, Paulo Roberto Abrão, Pessôa, Mário Guimarães, Mazo, Daniel Ferraz de Campos, Brandão-Mello, Carlos Eduardo, Reuter, Tânia, Martinelli, Ana de Lourdes Candolo, Gonzalez, Mário Peribanez, Nastri, Ana Catharina Seixas-Santos, Campos, Aléia Faustina, Lopes, Max Igor Banks Ferreira, Brito, José David Urbaez, Mendes-Corrêa, Maria Cássia
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Instituto de Medicina Tropical 2017
Θέματα:
Original Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679679/
https://ncbi.nlm.nih.gov/pubmed/29116287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1678-9946201759067
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια